About N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide
N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide (PubChem CID 71878112) has the molecular formula C15H15N7O3
and a molecular weight of 341.33 g/mol. Its IUPAC name is N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide.
Analyze N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide?
The IUPAC name of N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide (CID 71878112) is N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide.
What is the SMILES notation for N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide?
The canonical SMILES for N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide is O=C(Cn1nnc(-c2ccccc2)n1)Nc1nnc(C2CCCO2)o1.
What is the InChIKey of N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide?
The InChIKey is LMWGCBDBSNOFSJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H15N7O3/c23-12(16-15-19-18-14(25-15)11-7-4-8-24-11)9-22-20-13(17-21-22)10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,16,19,23).
What are the key properties of N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide?
N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide has a molecular weight of 341.33 g/mol, XLogP of 1.21, 5 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(oxolan-2-yl)-1,3,4-oxadiazol-2-yl]-2-(5-phenyltetrazol-2-yl)acetamide is sourced from PubChem (CID 71878112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).